Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Trial ID or NCT#

NCT00958841,29,30,27555

Status

not recruiting iconNOT RECRUITING

Purpose

This study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.

Official Title

An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rare Tumors of Neuroendocrine Origin

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Laurence Katznelson

Contact us to find out if this trial is right for you.

Contact

Cancer Clinical Trials Office
650-498-7061

View on ClinicalTrials.gov